The health effects of ambient PM2.5 and potential mechanisms

Ecotoxicology and Environmental Safety

Volumn 128, Issue , 2016, Pages 67-74

  Feng, Shaolong ^a   Gao, Dan ^a   Liao, Fen ^a   Zhou, Furong ^a   Wang, Xinming ^b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b GUANGZHOU INSTITUTE OF GEOCHEMISTRY   (China)

Author keywords

Genotoxicity; Health effect; Inflammation; Oxidative stress; PM2.5

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ARYLDIALKYLPHOSPHATASE; CATALASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2E1; DNA; GAMMA INTERFERON; HEME OXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; AIR POLLUTANT; PARTICULATE MATTER;

DEVELOPING WORLD; EPIDEMIOLOGY; GENOTOXICITY; HEALTH IMPACT; PARTICULATE MATTER; PUBLIC HEALTH; TOXICOLOGY;

AIR POLLUTION CONTROL; AMBIENT AIR; ASTHMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHEMICAL COMPOSITION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE EXACERBATION; DNA DAMAGE; ECOTOXICOLOGY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL PROGENITOR CELL; ENVIRONMENTAL HEALTH; GENOTOXICITY; HEALTH HAZARD; HUMAN; IMMUNE DEFICIENCY; INFANCY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; METABOLIC ACTIVATION; MORBIDITY; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PHYSICAL CHEMISTRY; PREGNANCY OUTCOME; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; AIR POLLUTANT; ANIMAL; TOXICITY;

AIR POLLUTANTS; ANIMALS; HUMANS; PARTICULATE MATTER;

EID: 84958257707     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2016.01.030     Document Type: Review

References (133)

1. Adar S.D., et al. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution. PLoS Med 2013, 10(4):e1001430.
2. Abbas I., et al. Air pollution particulate matter (PM2.5)-induced gene expression of volatile organic compound and/or polycyclic aromatic hydrocarbon-metabolizing enzymes in an in vitro coculture lung model. Toxicol. In Vitro 2009, 23(1):37-46.
3. Andre V., et al. Mutagenicity and genotoxicity of PM2.5 issued from an urbano-industrialized area of Dunkerque (France). J. Appl.Toxicol. 2011, 31(2):131-138.
4. Burnett R.T., et al. An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ. Health Perspect. 2014, 122(4):397-403.
5. Belleudi V., et al. Impact of fine and ultrafine particles on emergency hospital admissions for cardiac and respiratory diseases. Epidemiology 2010, 21(3):414-423.
6. Bell M.L., et al. Associations of PM2.5 constituents and sources with hospital admissions: analysis of four counties in Connecticut and Massachusetts (USA) for persons >/=65 years of age. Environ. Health Perspect. 2014, 122(2):138-144.
7. Balasubramanian P., et al. Differential effects of inhalation exposure to PM2.5 on hypothalamic monoamines and corticotrophin releasing hormone in lean and obese rats. Neurotoxicology 2013, 36:106-111.
8. Brook R.D., et al. Reduced metabolic insulin sensitivity following sub-acute exposures to low levels of ambient fine particulate matter air pollution. Sci. Total Environ. 2013, 448:66-71.
9. Brook R.D., et al. Long-term fine particulate matter exposure and mortality from diabetes in Canada. Diabetes Care 2013, 36(10):3313-3320.
10. Bell M.L., et al. Relationship between birth weight and exposure to airborne fine particulate potassium and titanium during gestation. Environ. Res. 2012, 117:83-89.
11. Barrett J.R. Apples to apples: comparing PM2.5 exposures and birth outcomes in understudied countries. Environ. Health Perspect. 2014, 122(4):A110.
12. Churg A., Brauer M. Human lung parenchyma retains PM2.5. Am. J. Respir. Crit. Care Med. 1997, 155(6):2109-2111.
13. Crouse D.L., et al. Risk of nonaccidental and cardiovascular mortality in relation to long-term exposure to low concentrations of fine particulate matter: a Canadian national-level cohort study. Environ. Health Perspect. 2012, 120(5):708-714.
14. Chen H., et al. Risk of incident diabetes in relation to long-term exposure to fine particulate matter in Ontario, Canada. Environ. Health Perspect. 2013, 121(7):804-810.
15. Corsini E., et al. Comparison of wood smoke PM2.5 obtained from the combustion of FIR and beech pellets on inflammation and DNA damage in A549 and THP-1 human cell lines. Arch. Toxicol. 2013.
16. Chiu H.F., Yang C.Y. Short-term effects of fine particulate air pollution on ischemic stroke occurrence: a case-crossover study. J. Toxicol. Environ. Health A 2013, 76(21):1188-1197.
17. Chang C.C., et al. Fine particulate air pollution and hospital admissions for myocardial infarction in a subtropical city: Taipei, Taiwan. J. Toxicol. Environ. Health A 2013, 76(7):440-448.
18. Chen H., et al. Spatial association between ambient fine particulate matter and incident hypertension. Circulation 2013.
19. Duan Z., et al. Effects of PM2.5 exposure on Klebsiella pneumoniae clearance in the lungs of rats. Zhonghua Jie He He Hu Xi Za Zhi 2013, 36(11):836-840.
20. Davel A.P., et al. Endothelial dysfunction in the pulmonary artery induced by concentrated fine particulate matter exposure is associated with local but not systemic inflammation. Toxicology 2012, 295(1-3):39-46.
21. Darrow L.A., et al. Air pollution and acute respiratory infections among children 0-4 years of age: an 18-year time-series study. Am. J. Epidemiol. 2014, 180(10):968-977.
22. Deng X., et al. PM2.5-induced oxidative stress triggers autophagy in human lung epithelial A549 cells. Toxicol. In Vitro 2013, 27(6):1762-1770.
23. de Brito K.C., et al. Comparative genotoxicity of airborne particulate matter (PM2.5) using Salmonella, plants and mammalian cells. Ecotoxicol. Environ. Saf. 2013, 94:14-20.
24. Dysart M.M., et al. Environmental particulate (PM2.5) augments stiffness-induced alveolar epithelial cell mechanoactivation of transforming growth factor beta. PLoS One 2014, 9(9):e106821.
25. Doherty S.P., et al. Detection of changes in alveolar macrophage iron status induced by select PM2.5-associated components using iron-response protein binding activity. Inhal. Toxicol. 2007, 19(6-7):553-562.
26. Dieme D., et al. Relationship between physicochemical characterization and toxicity of fine particulate matter (PM2.5) collected in Dakar city (Senegal). Environ. Res. 2012, 113:1-13.
27. Dergham M., et al. Prooxidant and proinflammatory potency of air pollution particulate matter (PM(2).(5)(-)(0).(3)) produced in rural, urban, or industrial surroundings in human bronchial epithelial cells (BEAS-2B). Chem. Res. Toxicol. 2012, 25(4):904-919.
28. Deng X., et al. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Cell Biol. Toxicol. 2013, 29(3):143-157.
29. Dagher Z., et al. Role of nuclear factor-kappa B activation in the adverse effects induced by air pollution particulate matter (PM2.5) in human epithelial lung cells (L132) in culture. J. Appl. Toxicol. 2007, 27(3):284-290.
30. Evans J., et al. Estimates of global mortality attributable to particulate air pollution using satellite imagery. Environ. Res. 2013, 120:33-42.
31. Elliott C.T., Copes R. Burden of mortality due to ambient fine particulate air pollution (PM2.5) in interior and Northern BC. Can. J. Public Health 2011, 102(5):390-393.
32. Franklin M., Zeka A., Schwartz J. Association between PM2.5 and all-cause and specific-cause mortality in 27 US communities. J. Expo. Sci. Environ. Epidemiol. 2007, 17(3):279-287.
33. Fann N., et al. Estimating the national public health burden associated with exposure to ambient PM2.5 and ozone. Risk Anal. 2012, 32(1):81-95.
34. Fleischer N.L., et al. Outdoor air pollution, preterm birth, and low birth weight: analysis of the world health organization global survey on maternal and perinatal health. Environ. Health Perspect. 2014, 122(4):425-430.
35. Feng S., Cao Z., Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim. Biophys. Acta 2013, 1836(2):197-210.
36. Gleason J.A., Bielory L., Fagliano J.A. Associations between ozone, PM2.5, and four pollen types on emergency department pediatric asthma events during the warm season in New Jersey: a case-crossover study. Environ. Res. 2014, 132:421-429.
37. Gurley E.S., et al. Indoor exposure to particulate matter and the incidence of acute lower respiratory infections among children: a birth cohort study in urban Bangladesh. Indoor Air 2013, 23(5):379-386.
38. Gualtieri M., et al. Airborne urban particles (Milan winter-PM2.5) cause mitotic arrest and cell death: effects on DNA, mitochondria, AhR binding and spindle organization. Mutat. Res. 2011, 713(1-2):18-31.
39. Gualtieri M., et al. Gene expression profiling of A549 cells exposed to Milan PM2.5. Toxicol. Lett. 2012, 209(2):136-145.
40. Gehling W., Dellinger B. Environmentally persistent free radicals and their lifetimes in PM2.5. Environ. Sci. Technol. 2013, 47(15):8172-8178.
41. Gehling W., Khachatryan L., Dellinger B. Hydroxyl radical generation from environmentally persistent free radicals (EPFRs) in PM2.5. Environ. Sci. Technol. 2014, 48(8):4266-4272.
42. Gilli G., et al. The mutagenic hazards of environmental PM2.5 in Turin. Environ. Res. 2007, 103(2):168-175.
43. Gioda A., Fuentes-Mattei E., Jimenez-Velez B. Evaluation of cytokine expression in BEAS cells exposed to fine particulate matter (PM2.5) from specialized indoor environments. Int. J. Environ. Health Res. 2011, 21(2):106-119.
44. Hu Z. Spatial analysis of MODIS aerosol optical depth, PM2.5 and chronic coronary heart disease. Int. J. Health Geogr. 2009, 8:27.
45. Habre R., et al. The effects of PM2.5 and its components from indoor and outdoor sources on cough and wheeze symptoms in asthmatic children. J. Expo. Sci. Environ. Epidemiol. 2014, 24(4):380-387.
46. Huang Q., et al. Effects of water soluble PM2.5 extracts exposure on human lung epithelial cells (A549): a proteomic study. J. Appl. Toxicol. 2013.
47. Huang N.H., Wang Q., Xu D.Q. Immunological effect of PM2.5 on cytokine production in female Wistar rats. Biomed. Environ. Sci. 2008, 21(1):63-68.
48. Hsieh Y.L., Tsai S.S., Yang C.Y. Fine particulate air pollution and hospital admissions for congestive heart failure: a case-crossover study in Taipei. Inhal. Toxicol. 2013, 25(8):455-460.
49. He F., et al. Individual-level PM(2).(5) exposure and the time course of impaired heart rate variability: the APACR Study. J. Expo. Sci. Environ. Epidemiol. 2011, 21(1):65-73.
50. Haberzettl P., et al. Exposure to ambient air fine particulate matter prevents VEGF-induced mobilization of endothelial progenitor cells from the bone marrow. Environ. Health Perspect. 2012, 120(6):848-856.
51. Hummasti S., Hotamisligil G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res. 2010, 107(5):579-591.
52. Hyder A., et al. PM2.5 exposure and birth outcomes: use of satellite- and monitor-based data. Epidemiology 2014, 25(1):58-67.
53. Hertz-Picciotto I., et al. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin. Pharmacol. Toxicol. 2008, 102(2):146-154.
54. Janssen N.A., et al. Short-term effects of PM2.5, PM10 and PM2.5-10 on daily mortality in The Netherlands. Sci. Total Environ. 2013, 463-464:20-26.
55. Jacobson Lda S., et al. Association between fine particulate matter and the peak expiratory flow of schoolchildren in the Brazilian subequatorial Amazon: a panel study. Environ. Res. 2012, 117:27-35.
56. Jung K.H., et al. Childhood exposure to fine particulate matter and black carbon and the development of new wheeze between ages 5 and 7 in an urban prospective cohort. Environ. Int. 2012, 45:44-50.
57. Jedrychowski W.A., et al. Intrauterine exposure to fine particulate matter as a risk factor for increased susceptibility to acute broncho-pulmonary infections in early childhood. Int. J. Hyg. Environ. Health 2013, 216(4):395-401.
58. Jacquemin B., et al. Source category-specific PM2.5 and urinary levels of Clara cell protein CC16. The ULTRA study. Inhal. Toxicol. 2009, 21(13):1068-1076.
59. Jedrychowski W.A., et al. Prohypertensive effect of gestational personal exposure to fine particulate matter. Prospective cohort study in non-smoking and non-obese pregnant women. Cardiovasc. Toxicol. 2012, 12(3):216-225.
60. Jedrychowski W.A., et al. Variability of total exposure to PM2.5 related to indoor and outdoor pollution sources Krakow study in pregnant women. Sci. Total Environ. 2006, 366(1):47-54.
61. Jedrychowski W.A., et al. Dose-dependent relationship between prenatal exposure to fine particulates and exhaled carbon monoxide in non-asthmatic children. A population-based birth cohort study. Int. J. Occup. Med. Environ. Health 2013, 26(1):73-82.
62. Kloog I., et al. Long- and short-term exposure to PM2.5 and mortality: using novel exposure models. Epidemiology 2013, 24(4):555-561.
63. Kloog I., et al. Using new satellite based exposure methods to study the association between pregnancy PM(2).(5) exposure, premature birth and birth weight in Massachusetts. Environ. Health 2012, 11:40.
64. Kendall M. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293(4):L1053-L1058.
65. Kamal A.S., et al. PM2.5-induced changes in cardiac function of hypertensive rats depend on wind direction and specific sources in Steubenville, Ohio. Inhal. Toxicol. 2011, 23(7):417-430.
66. Krishnan R.M., et al. Vascular responses to long- and short-term exposure to fine particulate matter: MESA air (multi-ethnic study of atherosclerosis and air pollution). J. Am. Coll. Cardiol. 2012, 60(21):2158-2166.
67. Kile M.L., et al. A panel study of occupational exposure to fine particulate matter and changes in DNA methylation over a single workday and years worked in boilermaker welders. Environ. Health 2013, 12(1):47.
68. Kannan S., et al. Exposures to airborne particulate matter and adverse perinatal outcomes: a biologically plausible mechanistic framework for exploring potential effect modification by nutrition. Environ. Health Perspect. 2006, 114(11):1636-1642.
69. Kouassi K.S., et al. Oxidative damage induced in A549 cells by physically and chemically characterized air particulate matter (PM2.5) collected in Abidjan, Cote d'Ivoire. J. Appl. Toxicol. 2010, 30(4):310-320.
70. Longhin E., et al. Cell cycle alterations induced by urban PM2.5 in bronchial epithelial cells: characterization of the process and possible mechanisms involved. Part Fibre Toxicol. 2013, 10:63.
71. Leiva G.M., et al. A five-year study of particulate matter (PM2.5) and cerebrovascular diseases. Environ. Pollut. 2013, 181:1-6.
72. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473(7347):317-325.
73. Liu C., et al. Air pollution-mediated susceptibility to inflammation and insulin resistance: influence of CCR2 pathways in mice. Environ. Health Perspect. 2014, 122(1):17-26.
74. Madrigano J., et al. Long-term exposure to PM2.5 and incidence of acute myocardial infarction. Environ. Health Perspect. 2013, 121(2):192-196.
75. Montoya-Estrada A., et al. Urban PM2.5 activates GAPDH and induces RBC damage in COPD patients. Front. Biosci. (Schol Ed) 2013, 5:638-649.
76. Maes M., et al. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?. Expert Opin. Ther. Targets 2014, 18(5):495-512.
77. Montiel-Davalos A., Alfaro-Moreno E., Lopez-Marure R. PM2.5 and PM10 induce the expression of adhesion molecules and the adhesion of monocytic cells to human umbilical vein endothelial cells. Inhal. Toxicol. 2007, 19(Suppl 1):91-98.
78. Mendez R., et al. Exposure to fine airborne particulate matter induces macrophage infiltration, unfolded protein response and lipid deposition in white adipose tissue. Am. J. Transl. Res. 2013, 5(2):224-234.
79. Maciejczyk P., et al. Oxidant generation capacity of source-apportioned PM2.5. Inhal. Toxicol. 2010, 22(Suppl 2):29-36.
80. Mitkus R.J., et al. Comparative physicochemical and biological characterization of NIST interim reference material PM2.5 and SRM 1648 in human A549 and mouse RAW264.7 cells. Toxicol. In Vitro 2013, 27(8):2289-2298.
81. Nachman K.E., Parker J.D. Exposures to fine particulate air pollution and respiratory outcomes in adults using two national datasets: a cross-sectional study. Environ. Health 2012, 11:25.
82. Niu J., et al. The role of metal components in the cardiovascular effects of PM2.5. PLoS One 2013, 8(12):e83782.
83. Nam H.Y., et al. The role of nitric oxide in the particulate matter (PM2.5)-induced NFkappaB activation in lung epithelial cells. Toxicol. Lett. 2004, 148(1-2):95-102.
84. Nikasinovic L., et al. Nasal inflammation and personal exposure to fine particles PM2.5 in asthmatic children. J. Allergy Clin. Immunol. 2006, 117(6):1382-1388.
85. Ogino K., et al. Allergic airway inflammation by nasal inoculation of particulate matter (PM2.5) in NC/Nga mice. PLoS One 2014, 9(3):e92710.
86. Oh S.M., et al. Organic extracts of urban air pollution particulate matter (PM2.5)-induced genotoxicity and oxidative stress in human lung bronchial epithelial cells (BEAS-2B cells). Mutat. Res. 2011, 723(2):142-151.
87. Pinkerton K.E., et al. Distribution of particulate matter and tissue remodeling in the human lung. Environ. Health Perspect. 2000, 108(11):1063-1069.
88. Pozzi R., et al. Inflammatory mediators induced by coarse (PM2.5-10) and fine (PM2.5) urban air particles in RAW 264.7 cells. Toxicology 2003, 183(1-3):243-254.
89. Pandey P., et al. Temporal distribution of fine particulates (PM2.5, PM10), potentially toxic metals, PAHs and Metal-bound carcinogenic risk in the population of Lucknow city, India. J. Environ. Sci. Health A Toxicol. Hazard. Subst. Environ. Eng. 2013, 48(7):730-745.
90. Psoter K.J., et al. Fine particulate matter exposure and initial pseudomonas aeruginosa acquisition in cystic fibrosis. Ann. Am. Thorac. Soc. 2015, 12(3):385-391.
91. Pereira G., et al. Fine particulate matter and risk of preterm birth in connecticut in 2000-2006: a longitudinal study. Am. J. Epidemiol. 2013.
92. Riva D.R., et al. Low dose of fine particulate matter (PM2.5) can induce acute oxidative stress, inflammation and pulmonary impairment in healthy mice. Inhal. Toxicol. 2011, 23(5):257-267.
93. Rumelhard M., et al. Effects of PM2.5 components in the release of amphiregulin by human airway epithelial cells. Toxicol. Lett. 2007, 168(2):155-164.
94. Reis M.A., et al. High airborne PM2.5 chlorine concentrations link to diabetes surge in Portugal. Sci. Total Environ. 2009, 407(21):5726-5734.
95. Reche C., et al. A multidisciplinary approach to characterise exposure risk and toxicological effects of PM(1)(0) and PM(2).(5) samples in urban environments. Ecotoxicol. Environ. Saf. 2012, 78:327-335.
96. Rumelhard M., et al. Expression and role of EGFR ligands induced in airway cells by PM2.5 and its components. Eur. Respir. J. 2007, 30(6):1064-1073.
97. Sun L., et al. Ambient fine particulate matter and ozone exposures induce inflammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet. Part Fibre Toxicol. 2013, 10(1):43.
98. Schneider A., et al. Association of cardiac and vascular changes with ambient PM2.5 in diabetic individuals. Part Fibre Toxicol. 2010, 7:14.
99. Schneider A., et al. Ambient PM2.5 exposure up-regulates the expression of costimulatory receptors on circulating monocytes in diabetic individuals. Environ. Health Perspect. 2011, 119(6):778-783.
100. Savitz D.A., et al. Ambient fine particulate matter, nitrogen dioxide and term birth weight in New York, New York. Am. J. Epidemiol. 2013.
101. Soberanes S., et al. Mitochondrial complex III-generated oxidants activate ASK1 and JNK to induce alveolar epithelial cell death following exposure to particulate matter air pollution. J. Biol. Chem. 2009, 284(4):2176-2186.
102. Schober W., et al. Organic extracts of urban aerosol (
103. Thaller E.I., et al. Moderate increases in ambient PM2.5 and ozone are associated with lung function decreases in beach lifeguards. J. Occup. Environ. Med. 2008, 50(2):202-211.
104. Tsai S.S., Chang C.C., Yang C.Y. Fine particulate air pollution and hospital admissions for chronic obstructive pulmonary disease: a case-crossover study in taipei. Int. J. Environ. Res. Public Health 2013, 10(11):6015-6026.
105. Torres-Ramos Y.D., et al. Urban PM2.5 induces ROS generation and RBC damage in COPD patients. Front. Biosci. (Elite Ed) 2011, 3:808-817.
106. Thayer J.F., Yamamoto S.S., Brosschot J.F. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int. J. Cardiol. 2010, 141(2):122-131.
107. Traversi D., et al. Mutagenic properties of PM2.5 urban pollution in the northern Italy: the nitro-compounds contribution. Environ. Int. 2009, 35(6):905-910.
108. Tong G., et al. Traffic-related PM2.5 regulates IL-2 releasing in Jurkat T cells by calcium signaling pathway. Wei Sheng Yan Jiu 2013, 42(5):822-827.
109. Vempilly J., et al. The synergetic effect of ambient PM2.5 exposure and rhinovirus infection in airway dysfunction in asthma: a pilot observational study from the central valley of california. Exp. Lung Res. 2013, 39(10):434-440.
110. Wang G., et al. Effects of ozone and fine particulate matter (PM2.5) on rat cardiac autonomic nervous system and systemic inflammation. Wei Sheng Yan Jiu 2013, 42(4):554-560.
111. WHO's global air-quality guidelines. Lancet, 2006. 368(9544): p. 1302.
112. Watterson T.L., et al. Effects of PM2.5 collected from Cache Valley Utah on genes associated with the inflammatory response in human lung cells. J. Toxicol. Environ. Health A 2007, 70(20):1731-1744.
113. Wang G., et al. Rat lung response to ozone and fine particulate matter (PM) exposures. Environ. Toxicol. 2013.
114. Wu S., et al. Chemical constituents of fine particulate air pollution and pulmonary function in healthy adults: the healthy volunteer natural relocation study. J. Hazard. Mater. 2013, 260:183-191.
115. Willers S.M., et al. Fine and coarse particulate air pollution in relation to respiratory health in Sweden. Eur. Respir. J. 2013, 42(4):924-934.
116. Wang G., et al. Effects of ozone and fine particulate matter (PM(2.5)) on rat system inflammation and cardiac function. Toxicol. Lett. 2013, 217(1):23-33.
117. Wellenius G.A., et al. Ambient fine particulate matter alters cerebral hemodynamics in the elderly. Stroke 2013, 44(6):1532-1536.
118. Wold L.E., et al. Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution. Circ. Heart Fail. 2012, 5(4):452-461.
119. Woodruff T.J., Parker J.D., Schoendorf K.C. Fine particulate matter (PM2.5) air pollution and selected causes of postneonatal infant mortality in California. Environ. Health Perspect. 2006, 114(5):786-790.
120. Weichenthal S.A., Godri-Pollitt K., Villeneuve P.J. PM2.5, oxidant defence and cardiorespiratory health: a review. Environ. Health 2013, 12:40.
121. Win-Shwe T.T., et al. Effects of acute single intranasal instillation of secondary organic aerosol on neurological and immunological biomarkers in the brain and lung of BALB/c mice. J. Toxicol. Sci. 2013, 38(1):71-82.
122. Williams L., et al. Fine particulate matter (PM(2).(5)) air pollution and immune status among women in the Seattle area. Arch. Environ. Occup. Health 2011, 66(3):155-165.
123. Xu D., et al. Study of ambient PM2.5 on the influence of the inflammation injury and the immune function of subchronic exposure rats. Wei Sheng Yan Jiu 2008, 37(4):423-428.
124. Xie Y., et al. Preexposure to PM2.5 exacerbates acute viral myocarditis associated with Th17 cell. Int. J. Cardiol. 2013, 168(4):3837-3845.
125. Xu X., et al. Inflammatory response to fine particulate air pollution exposure: neutrophil versus monocyte. PLoS One 2013, 8(8):e71414.
126. Xu H., et al. Genotoxicity of total and fractionated extractable organic matter in fine air particulate matter from urban Guangzhou: comparison between haze and nonhaze episodes. Environ. Toxicol. Chem. 2008, 27(1):206-212.
127. Ying Z., et al. Long-term exposure to concentrated ambient PM2.5 increases mouse blood pressure through abnormal activation of the sympathetic nervous system: a role for hypothalamic inflammation. Environ. Health Perspect. 2014, 122(1):79-86.
128. Yang J.L., et al. Involvement of heme oxygenase in PM2.5-toxicity in human umbilical vein endothelial cells. Zhonghua Xin Xue Guan Bing Za Zhi 2013, 41(11):955-961.
129. Zanobetti A., et al. A national case-crossover analysis of the short-term effect of PM2.5 on hospitalizations and mortality in subjects with diabetes and neurological disorders. Environ. Health 2014, 13(1):38.
130. Zhao J., et al. The biological effects of individual-level PM2.5 exposure on systemic immunity and inflammatory response in traffic policemen. Occup. Environ. Med. 2013.
131. Zhao H., et al. Exposure to particular matter increases susceptibility to respiratory Staphylococcus aureus infection in rats via reducing pulmonary natural killer cells. Toxicology 2014, 325:180-188.
132. Zaiss D.M., et al. Emerging functions of amphiregulin in orchestrating immunity, inflammation and tissue repair. Immunity 2015, 42(2):216-226.
133. Zhao C., et al. Involvement of TLR2 and TLR4 and Th1/Th2 shift in inflammatory responses induced by fine ambient particulate matter in mice. Inhal. Toxicol. 2012, 24(13):918-927.